Global Bio Fund is the world's first seed accelerator fund dedicated to empowering women bio entrepreneurs. The firm focuses on early-stage investments, particularly in the biotechnology sector, supporting innovative startups led by women. Their typical investment round is Series A, providing crucial funding to help these companies scale and succeed in the competitive biotech landscape.
Notable portfolio companies include Geneos Therapeutics, which has raised $17 million. The fund's key partners and decision-makers are committed to fostering diversity and innovation in biotech. Global Bio Fund offers unique value-add services such as mentorship, networking opportunities, and strategic guidance tailored to the specific needs of women-led biotech startups, ensuring they have the resources and support necessary to thrive.
Global Bio Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
